Transplacental Total IgG Transfer in Twin Pregnancies
Carregando...
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Citação
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, v.72, n.6, p.555-560, 2014
Resumo
ProblemIn twin pregnancies, factors that influence total umbilical cord IgG concentration and IgG transfer ratio are not well known. MethodBlood samples were prospectively collected from 57 twin pregnancies. Stepwise multivariate regression analysis was used to evaluate the association between total IgG levels in the umbilical cord blood and IgG transfer ratio according to serum IgG concentration, pregnancy chorionicity, the presence of abnormal umbilical artery pulsatility index, intrauterine growth restriction, gestational age at delivery (GAD), birthweight, and placental weight. ResultsUmbilical cord IgG concentration showed a positive correlation with serum IgG concentration and GAD; levels were significantly lower in monochorionic compared with dichorionic pregnancies. IgG transfer ratio also increased with GAD but was inversely correlated with serum IgG concentration levels. ConclusionIn twin pregnancies, besides serum IgG concentration and GAD, chorionicity also influences umbilical cord IgG concentration. Monochorionic twins have lower IgG cord concentration than dichorionic twins.
Palavras-chave
IgG concentration, immunoglobulins, maternal transfer, multiple pregnancy
Referências
- Alexander GR, 2006, MULTIPLE PREGNANCY E, P3
- ARDUINI D, 1990, J PERINAT MED, V18, P165, DOI 10.1515/jpme.1990.18.3.165
- Brambell FWR, 1958, BIOL REV, V33, P485
- BRYAN EM, 1976, ARCH DIS CHILD, V51, P354
- BRYAN EM, 1977, EARLY HUM DEV, V1, P133, DOI 10.1016/0378-3782(77)90014-7
- Domingues AP, 2007, ACTA OBSTET GINECOL, V1, P163
- GARTY BZ, 1994, CLIN DIAGN LAB IMMUN, V1, P667
- Gitlin D, 1982, IMMUNOLOGY OBSTET GY, P240
- Goncalves G, 1999, EPIDEMIOL INFECT, V122, P273, DOI 10.1017/S0950268899002046
- Hack KE, 2008, BJOG-INT J OBSTET GY, V115, P58, DOI 10.1111/j.1471-0528.2007.01556.x
- Kent EM, 2012, AM J OBSTET GYNECOL, V207
- Alexander G R, 1998, Clin Obstet Gynecol, V41, P114
- Lessa ALS, 2011, FEMS IMMUNOL MED MIC, V62, P236, DOI 10.1111/j.1574-695X.2011.00807.x
- MALEK A, 1994, AM J REPROD IMMUNOL, V32, P8
- Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
- Malek A, 2003, VACCINE, V21, P3362, DOI 10.1016/S0264-410X(03)00333-5
- Okoko BJ, 2001, J INFECT DIS, V184, P627, DOI 10.1086/322808
- Okoko JB, 2001, TROP MED INT HEALTH, V6, P529, DOI 10.1046/j.1365-3156.2001.00741.x
- Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
- PITCHERWILMOTT RW, 1980, CLIN EXP IMMUNOL, V41, P303
- ROBERTSON EG, 1983, AM J OBSTET GYNECOL, V147, P170
- SAJI F, 1994, PLACENTA, V15, P453, DOI 10.1016/S0143-4004(05)80415-1
- van den Berg JP, 2010, PEDIATR INFECT DIS J, V29, P801, DOI 10.1097/INF.0b013e3181dc4f77
- Vayssiere C, 2011, EUR J OBSTET GYN R B, V156, P12, DOI 10.1016/j.ejogrb.2010.12.045
- Vergani P, 2013, AM J PERINAT, V30, P545, DOI 10.1055/s-0032-1329183
- Vijayakanthi N, 2013, BIOMED RES INT, DOI 10.1155/2013/756209